Source avec lien : Journal of Occupational & Environmental Medicine, 65(4). 10.1097/JOM.0000000000002800
L’objectif de cette étude était d’explorer la persistance à long terme de la déficience liée à COVID-19 et la capacité à travailler après la phase aiguë de la maladie.
Our study demonstrates that the proportion of workers compensation claims with longer lost time from work after infection with SARS-CoV-2 decreased over the study duration. These data support that factors such as population level immunity though natural infection vaccination and mutations in the SARS-CoV-2 genome may be contributing to overall decreased morbidity or functional impairment from SARS-CoV-2. Objective: To explore the long-term persistence of COVID-19–related impairment and the ability to work after the acute phase of the illness. Method: The 19,101 COVID-19 workers’ compensation claims filed between January 1, 2020, and December 31, 2021, with follow-up to May 31, 2022, were analyzed. Results: The average time lost from work decreased from 77 days in the first quarter of 2020 to 9.2 days in the fourth quarter of 2021, and the proportion of claims with 30 days or more of lost time decreased from 40.4% to 2.8 days in the same time frame. Conclusion: COVID-19 indemnity claims filed in later quarters of the SARS-CoV-2 pandemic have much lower average time lost from work and lower proportions of workers’ compensation claims with more than 30, 60, and 150 days of lost time compared with earlier quarters.